Cost-Effectiveness Analysis of Adjuvant Neratinib Following Trastuzumab in Early-Stage HER2-Positive Breast Cancer

Detalles Bibliográficos
Autores principales: Tran, Phuong T., Diaby, Vakaramoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391235/
https://www.ncbi.nlm.nih.gov/pubmed/32011959
http://dx.doi.org/10.18553/jmcp.2020.26.2.221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391235/
https://www.ncbi.nlm.nih.gov/pubmed/32011959
http://dx.doi.org/10.18553/jmcp.2020.26.2.221

Ejemplares similares